Variable phenotype of pseudohypoparathyroidism in children

Background. Pseudohypoparathyroidism (PHP) is a heterogeneous group of disorders associated with tissue insensitivity to parathyroid hormone. PHP is characterized by genetic heterogeneity and variable phenotype. In addition to the hypocalcemic syndrome and resistance to parathyroid hormone, PHP is also characterized by phenotypic features and resistance to other hormones (TSH, LH, FSH, and GHRH), which are known as Albright Hereditary Osteodystrophy (AHO). Until recently, no analysis of large cohorts of patients with PHP has been performed in Russian literature.

Objective — to examine a large cohort of patients with PHP and assess the clinical features of PHP.

Material and methods. A group consisting of 32 patients with different variants of course of the disease who had been examined at the Endocrinology Research Center in 2014—2016 was analyzed.

Results. Features of AHO phenotype in addition to hormonal resistance were identified in 16 (50%) patients; one of them had one feature (brachydactyly) and 15 patients had two and more features of AHO. Besides insensitivity to PTH, TSH resistance was found in 22 (68.75%) patients and one patient had resistance to PTH, TSH and LH/FSH. Hypothyroidism manifested before hypocalcaemia in 4 patients. Obesity was the first complaint in 8 patients; 5 of them had subclinical hypocalcaemia and the remaining 3 patients had an elevated PTH level with the normal level of calcium at the time of first examination. The most typical clinical signs of hypocalcaemia in 23 (72%) patients were seizures. Thirteen of them were misdiagnosed with epilepsy and had been followed by a neurologist for a period ranging between 2 months and 7 years before hypocalcaemia was revealed.

Conclusions. Pseudohypoparathyroidism is a rare genetic disorder associated with resistance to parathyroid hormone, which can have a lot of other clinical features in addition to the symptoms of PTH resistance. Obesity or hypothyroidism can be the earliest manifestation of PHP preceding hypocalcaemia. Evaluation of serum calcium level is important for all pediatric patients with seizures to timely diagnose hypocalcaemia and avoid misdiagnosing.

pseudohypoparathyroidism , albright Hereditary Osteodystrophy (AHO) , hypocalcaemia , seizures

1. Albbight F, Bubnett С, Smith P, Paeson W. Pseudohypoparathyroidism—an example of ‘Seabright-Bantam syndrome. Report of three cases. Endocrinology.1942;30:922-932.

2. Weinstein LS, Yu S, Warner DR, Liu J. Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting. Endocr Rev. 2001;22(5):675-705. doi: 10.1210/edrv.22.5.0439

3. Mantovani G. Clinical review: Pseudohypoparathyroidism: diagnosis and treatment. J Clin Endocrinol Metab. 2011;96(10):3020-3030. doi: 10.1210/jc.2011-1048

4. Elli FM, Linglart A, Garin I, et al. The Prevalence of GNAS Deficiency-Related Diseases in a Large Cohort of Patients Characterized by the EuroPHP Network. J Clin Endocrinol Metab. 2016;101(10):3657-3668. doi: 10.1210/jc.2015-4310

5. Thiele S, Mantovani G, Barlier A, et al. From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network. Eur J Endocrinol. 2016;175(6):1-17. doi: 10.1530/EJE-16-0107

6. Long DN, Levine MA, Germain-Lee EL. Bone mineral density in pseudohypoparathyroidism type 1a. J Clin Endocrinol Metab. 2010;95(9):4465-4475. doi: 10.1210/jc.2010-0498

7. Chen YJ, Shu SG, Chi CS. Pseudohypoparathyroidism: report of seven cases. Acta Paediatr Taiwan. 2005;46(6):374-380.

8. Cohen RD, Vince FP. Pseudohypoparathyroidism with raised plasma alkaline phosphatase. Arch Dis Child. 1969;44(233):96-101.

9. Eubanks PJ, Stabile BE. Osteitis fibrosa cystica with renal parathyroid hormone resistance: a review of pseudohypoparathyroidism with insight into calcium homeostasis. Arch Surg. 1998;133(6):673-676.

10. Murray TM, Rao LG, Wong MM, et al. Pseudohypoparathyroidism with osteitis fibrosa cystica: direct demonstration of skeletal responsiveness to parathyroid hormone in cells cultured from bone. J Bone Miner Res.1993;8(1):83-91. doi: 10.1002/jbmr.5650080111

11. Roizen JD, Danzig J, Groleau V, et al. Resting Energy Expenditure Is Decreased in Pseudohypoparathyroidism Type 1A. J Clin Endocrinol Metab. 2016;101(3):880-888. doi: 10.1210/jc.2015-3895

12. Chagin AS, Kronenberg HM. Role of G-proteins in the differentiation of epiphyseal chondrocytes. J Mol Endocrinol. 2014;53(2):R39-R45. doi: 10.1530/JME-14-0093

13. Sakamoto A, Chen M, Kobayashi T, et al. Chondrocyte-specific knockout of the G protein G(s)alpha leads to epiphyseal and growth plate abnormalities and ectopic chondrocyte formation. J Bone Miner Res. 2005;20(4):663-671. doi: 10.1359/JBMR.041210

14. Regard JB, Malhotra D, Gvozdenovic-Jeremic J, et al. Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification. Nat Med. 2013;19(11):1505-1512. doi: 10.1038/nm.3314

15. Brehin AC, Colson C, Maupetit-Mehouas S, et al. Loss of me thylation at GNAS exon A/B is associated with increased intrauterine growth. J Clin Endocrinol Metab. 2015;100(4):E623-E631. doi: 10.1210/jc.2014-4047

16. Fernandez-Rebollo E, Lecumberri B, Gaztambide S, et al. Endocrine profile and phenotype-(epi)genotype correlation in Spanish patients with pseudohypoparathyroidism. J Clin Endocrinol Metab. 2013;98(5):E996-1006. doi: 10.1210/jc.2012-4164

17. Mantovani G, Ferrante E, Giavoli C, et al. Recombinant human GH replacement therapy in children with pseudohypoparathyroidism type Ia: first study on the effect on growth. J Clin Endocrinol Metab. 2010;95(11):5011-5017. doi: 10.1210/jc.2010-1649